A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery

References

• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–2252. doi:10.1056/NEJMra03501014657432
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-623374478
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–286. doi:10.5732/cjc.011.1039022507220
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. doi:10.1056/NEJMoa111208822646630
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot J, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–1098. doi:10.1016/S1470-2045(15)00040-626254683
   PubMed Web of Science ®Google Scholar
• Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–692. doi:10.1016/S1470-2045(11)70142-521684205
   PubMed Web of Science ®Google Scholar
• Morita M, Toh Y, Saeki H, et al. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer. Anticancer Res. 2012;32(8):3275–3282.22843902
   PubMed Web of Science ®Google Scholar
• Liao Z, Zhang Z, Jin J, et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys. 2004;60(5):1484–1493. doi:10.1016/j.ijrobp.2004.05.05615590179
   PubMed Web of Science ®Google Scholar
• Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992;16(6):1104–9;discussion 1110. doi:10.1007/BF02067069
   PubMed Web of Science ®Google Scholar
• Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6(9):659–668. doi:10.1016/S1470-2045(05)70288-616129366
   PubMed Web of Science ®Google Scholar
• Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19(2):305–313. doi:10.1200/JCO.2001.19.2.30511208820
   PubMed Web of Science ®Google Scholar
• Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086–1092. doi:10.1200/JCO.2007.12.959318309943
   PubMed Web of Science ®Google Scholar
• Greene FL, Sobin LH. The TNM system: our language for cancer care. J Surg Oncol. 2002;80(3):119–120. doi:10.1002/jso.1011412115792
   PubMed Web of Science ®Google Scholar
• Li Y, Lu Z, Che Y, et al. Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma. Oncoimmunology. 2017;6(11):e1356147. doi:10.1080/2162402X.2017.135614729147607
   PubMed Web of Science ®Google Scholar
• Li W, Liu J, Zhao H. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Aging (Albany NY). 2020;12(2):1512–1526. doi:10.18632/aging.10269731978896
   PubMedGoogle Scholar
• Yang Y, Huang X, Zhou L, et al. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma. BMC Cancer. 2019;19(1):526. doi:10.1186/s12885-019-5755-531151431
   PubMed Web of Science ®Google Scholar
• Zheng Y, Fu S, He T, et al. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis. Eur J Surg Oncol. 2018;44(8):1199–1204. doi:10.1016/j.ejso.2018.04.01129784506
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo XW, Yin XX, Liu YC, Ji SJ. Nomogram-integrated C-reactive protein/albumin ratio predicts efficacy and prognosis in patients with thoracic esophageal squamous cell carcinoma receiving chemoradiotherapy. Cancer Manag Res. 2019;11:9459–9468. doi:10.2147/CMAR.S22811331819611
   PubMed Web of Science ®Google Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R30776148
   PubMed Web of Science ®Google Scholar
• Gouveia-Fernandes S. Monocytes and macrophages in cancer: unsuspected roles. Adv Exp Med Biol. 2020;1219:161–185.32130699
   PubMed Web of Science ®Google Scholar
• Kovacs AR, Pal L, Szucs S, et al. [Phagocytic function of monocytes and neutrophil granulocytes in ovarian cancer]. Orv Hetil. 2018;159(33):1353–1359. Hungarian.30099907
   PubMed Web of Science ®Google Scholar
• Blot E, Chen W, Vasse M, et al. Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. Br J Cancer. 2003;88(8):1207–1212. doi:10.1038/sj.bjc.660087212698185
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/nature0132212490959
   PubMed Web of Science ®Google Scholar
• Shigeoka M, Urakawa N, Nakamura T, et al. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci. 2013;104(8):1112–1119. doi:10.1111/cas.1218823648122
   PubMed Web of Science ®Google Scholar
• Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65. doi:10.1111/j.1365-2982.2011.01834.x22248109
   PubMed Web of Science ®Google Scholar
• Xiao FK, Wang L, Zhang WC, Wang LD, Zhao LS. Preoperative prognostic nutritional index is a significant predictor of survival in esophageal squamous cell carcinoma patients. Nutr Cancer. 2021;73(2):215–220. doi:10.1080/01635581.2020.175712932336142
   PubMed Web of Science ®Google Scholar
• Takao K, Konishi H, Fujiwara H, et al. Clinical significance of prognostic nutritional index in the treatment of esophageal squamous cell carcinoma. In Vivo. 2020;34(6):3451–3457. doi:10.21873/invivo.1218433144453
   PubMed Web of Science ®Google Scholar
• Liu X, Qiu H, Kong P, Zhou Z, Sun X. Gastric cancer, nutritional status, and outcome. Onco Targets Ther. 2017;10:2107–2114. doi:10.2147/OTT.S13243228442919
   PubMed Web of Science ®Google Scholar
• Burgess NG, Wyeth JW. An audit of combined multichannel intraluminal impedance manometry in the assessment of dysphagia. J Gastroenterol Hepatol. 2011;26(Suppl 3):79–82. doi:10.1111/j.1440-1746.2011.06655.x21443716
   PubMed Web of Science ®Google Scholar
• Alrawashdeh W, Jones R, Dumartin L, et al. Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. Mol Oncol. 2019;13(5):1075–1091. doi:10.1002/1878-0261.1246330690892
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.02520303878
   PubMed Web of Science ®Google Scholar
• Koike Y, Miki C, Okugawa Y, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98(7):540–544. doi:10.1002/jso.2115418937231
   PubMed Web of Science ®Google Scholar
• Nakatani M, Migita K, Matsumoto S, et al. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30(8):1–7. doi:10.1093/dote/dox020
   PubMed Web of Science ®Google Scholar
• Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):S79–S84. doi:10.1007/s10875-012-9847-023225204
   PubMed Web of Science ®Google Scholar
• Geng Y, Shao Y, Zhu D, et al. Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep. 2016;6:39482. doi:10.1038/srep3948228000729
   PubMed Web of Science ®Google Scholar
• Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36–42. doi:10.1016/j.jtho.2016.10.01627810391
   PubMed Web of Science ®Google Scholar
• Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662–1669. doi:10.1056/NEJMoa02234312444180
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-420180029
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-071315534099
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. doi:10.1186/1472-6947-8-5319036144
   PubMed Web of Science ®Google Scholar
• Pepe MS, Fan J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): a misleading measure of prediction improvement even with independent test data sets. Stat Biosci. 2015;7(2):282–295. doi:10.1007/s12561-014-9118-026504496
   PubMedGoogle Scholar
• Hayashi K, Eguchi S. The power-integrated discriminant improvement: an accurate measure of the incremental predictive value of additional biomarkers. Stat Med. 2019;38(14):2589–2604. doi:10.1002/sim.813530859601
   PubMed Web of Science ®Google Scholar
• Ludmir EB, Palta M, Willett CG, Czito BG. Total neoadjuvant therapy for rectal cancer: an emerging option. Cancer Am Cancer Soc. 2017;123(9):1497–1506.
   Google Scholar
• Cain H, Macpherson IR, Beresford M, et al. Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol (R Coll Radiol). 2017;29(10):642–652. doi:10.1016/j.clon.2017.06.00328669449
   PubMed Web of Science ®Google Scholar
• Xu JZ, Wang WQ, Zhang SR, et al. Neoadjuvant therapy is essential for resectable pancreatic cancer. Curr Med Chem. 2019;26(40):7196–7211. doi:10.2174/092986732566618041310172229651946
   PubMed Web of Science ®Google Scholar
• Yi Y, Li B, Sun H, et al. Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma. Tumour Biol. 2010;31(4):333–340. doi:10.1007/s13277-010-0041-920490963
   PubMedGoogle Scholar
• Tasdogan A, Faubert B, Ramesh V, et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 2020;577(7788):115–120. doi:10.1038/s41586-019-1847-231853067
   PubMed Web of Science ®Google Scholar
• Chen PH, Cai L, Huffman K, et al. Metabolic diversity in human non-small cell lung cancer cells. Mol Cell. 2019;76(5):838–851.e5. doi:10.1016/j.molcel.2019.08.02831564558
   PubMed Web of Science ®Google Scholar
• Muir A, Vander HM. The nutrient environment affects therapy. Science. 2018;360(6392):962–963. doi:10.1126/science.aar598629853672
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–1005. Japanese.6438478
   PubMedGoogle Scholar
• Nozoe T, Ninomiya M, Maeda T, et al. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40(5):440–443. doi:10.1007/s00595-009-4065-y20425547
   PubMed Web of Science ®Google Scholar
• Nozoe T, Kimura Y, Ishida M, et al. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28(4):396–400. doi:10.1053/ejso.2002.125712099649
   PubMed Web of Science ®Google Scholar
• Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268–274. doi:10.1002/bjs.730520960457
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao P, Chen X, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7(36):58543–58552. doi:10.18632/oncotarget.1014827344182
   PubMedGoogle Scholar
• Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–1182. doi:10.1016/j.ejso.2016.05.02927293109
   PubMed Web of Science ®Google Scholar
• Chen P, Wang C, Cheng B, et al. Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer. Onco Targets Ther. 2017;10:3107–3118. doi:10.2147/OTT.S13885428790844
   PubMed Web of Science ®Google Scholar
• Chen S, Yan H, Du J, et al. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis. Clin Chim Acta. 2018;482:203–208. doi:10.1016/j.cca.2018.04.01229653085
   PubMed Web of Science ®Google Scholar
• Kos FT, Hocazade C, Kos M, et al. Assessment of prognostic value of “neutrophil to lymphocyte ratio” and “prognostic nutritional index” as a sytemic inflammatory marker in non-small cell lung cancer. Asian Pac J Cancer Prev. 2015;16(9):3997–4002. doi:10.7314/APJCP.2015.16.9.399725987075
   PubMedGoogle Scholar
• Mori S, Usami N, Fukumoto K, et al. The significance of the prognostic nutritional index in patients with completely resected non-small cell lung cancer. PLoS One. 2015;10(9):e0136897. doi:10.1371/journal.pone.013689726356222
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–771. doi:10.1038/nrc361124154716
   PubMed Web of Science ®Google Scholar
• Talmor M, Mirza A, Turley S, et al. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol. 1998;28(3):811–817. doi:10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.0.CO;2-S9541575
   PubMed Web of Science ®Google Scholar
• Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921–925. doi:10.1126/science.125251024812208
   PubMed Web of Science ®Google Scholar
• Kitamura T, Doughty-Shenton D, Cassetta L, et al. Monocytes differentiate to immune suppressive precursors of metastasis-associated macrophages in mouse models of metastatic breast cancer. Front Immunol. 2017;8:2004. doi:10.3389/fimmu.2017.0200429387063
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–225. doi:10.1038/nature1013821654748
   PubMed Web of Science ®Google Scholar
• Shen SL, Fu SJ, Huang XQ, et al. Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer. 2014;14:744. doi:10.1186/1471-2407-14-74425280428
   PubMed Web of Science ®Google Scholar
• Huang SH, Waldron JN, Milosevic M, et al. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer Am Cancer Soc. 2015;121(4):545–555.
   Google Scholar
• Maeda R, Ishii G, Neri S, et al. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients. J Thorac Oncol. 2014;9(2):179–188. doi:10.1097/JTO.000000000000004424419414
   PubMed Web of Science ®Google Scholar
• Tsai YD, Wang CP, Chen CY, et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck. 2014;36(7):947–953. doi:10.1002/hed.2340023733351
   PubMed Web of Science ®Google Scholar
• Han LH, Jia YB, Song QX, et al. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2015;16(6):2245–2250. doi:10.7314/APJCP.2015.16.6.224525824745
   PubMedGoogle Scholar
• MacGuill M, Mulligan E, Ravi N, et al. Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer. Dis Esophagus. 2006;19(4):273–276. doi:10.1111/j.1442-2050.2006.00576.x16866859
   PubMed Web of Science ®Google Scholar
• Rohatgi PR, Swisher SG, Correa AM, et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer Am Cancer Soc. 2005;104(7):1349–1355.
   Google Scholar
• Donahue JM, Nichols FC, Li Z, et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009;87(2):392–399. doi:10.1016/j.athoracsur.2008.11.00119161745
   PubMed Web of Science ®Google Scholar
• Dexter SP, Sue-Ling H, McMahon MJ, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48(5):667–670. doi:10.1136/gut.48.5.66711302966
   PubMed Web of Science ®Google Scholar
• Okumura H, Uchikado Y, Matsumoto M, et al. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy. Int J Clin Oncol. 2013;18(2):329–334. doi:10.1007/s10147-012-0383-y22350023
   PubMed Web of Science ®Google Scholar
• Tong DK, Law S, Kwong DL, et al. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol. 2010;17(8):2184–2192. doi:10.1245/s10434-010-0995-220217248
   PubMed Web of Science ®Google Scholar
• Akutsu Y, Shuto K, Kono T, et al. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. J Surg Oncol. 2012;105(8):756–760. doi:10.1002/jso.2300722162007
   PubMed Web of Science ®Google Scholar
• Qiu Q, Duan J, Deng H, et al. Development and validation of a radiomics nomogram model for predicting postoperative recurrence in patients with esophageal squamous cell cancer who achieved pCR after neoadjuvant chemoradiotherapy followed by surgery. Front Oncol. 2020;10:1398. doi:10.3389/fonc.2020.0139832850451
   PubMed Web of Science ®Google Scholar
• Cai G, Yu J, Meng X. Predicting prognosis and adverse events by hematologic markers in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy. Cancer Manag Res. 2020;12:8497–8507. doi:10.2147/CMAR.S25705833061564
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Klaveren D, Lagarde SM, et al. Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery. Br J Surg. 2016;103(8):1039–1047. doi:10.1002/bjs.1014227115731
   PubMed Web of Science ®Google Scholar